Fritextsökning
Innehållstyper
-
Lidds får USA-patent
Utökar skyddet för sin behandling mot prostatacancer.
-
Grönt ljus för Pledpharma
Pledox försämrar inte effekten av cancerbehandlingen Folfox.
-
Less scars with new product
A new Swedish product for post surgical scar formation enters clinical development.
-
Think outside the... brain
Riitta Hari from the Brain Research Unit at the Helsinki University of Technology has recently stated that the mind is more than just the brain.
-
Blood type decide resistance to HIV
A Canadian-Swedish research team has found a blood type molecule that increases the resistance to HIV-infections.
-
Control of blood vessels can treat obesity
Mice exposed to low temperatures develop more blood vessels in their adipose tissue and metabolise body fat more quickly, according to a new study from Karolinska Institutet.
-
Recipharm investerar i Synthonics
Köper aktier för 17,6 miljoner och ingår samarbete med den amerikanska läkemedelstillverkaren.
-
DKK 1,3 billion for grand research
Danish Councils for Independent Research, DFF, will grant DKK 1,3 billion during 2009. Now has the application period started.
-
Positivt i Isofol Medicals studie
Publicerar lovande resultat mot tjocktarmscancer och planerar fler studier.
-
Framåt för konsulterna
Kristina Eliason, Linda Tinelius och David Albenius är nya i life science-teamet på Hays, där efterfrågan på specialkompetenser ökar.
-
Trio goes in for high tech medicines
The Swedish drug discovery company Beactica announces fragment-based drug discovery research collaboration with GE Healthcare and the University of Uppsala.
-
Motvind för Gilead
Medivirkonkurrentens hepatit C-läkemedel uppvisar oroande biverkningar.
-
Diamyd Medicals styrelse bemöter förslaget om likvidation
"De har gjort en dålig affär och vill ha pengarna tillbaka".
-
Glucose facilitates the use of indigo
The Finnish researcher Anne Vuorema oat the MTT Agrifood Research Finland proves in her new doctoral dissertation that glucose can serve as a reducing agent of indigo.
-
Meda gets access to Asia
The biotech giant Meda has recently acquires world-wide rights to the cancer breakthrough pain drug Onsolis.
-
Xvivo levererar till Florida
Under mars månad ska medtechbolaget leverera sin teknik för perfusion av lungor till USA. I dag fick företaget dessutom ett nytt patent i landet.
-
New partnering platform
EBD Group's Partnering One is the new partnering platform for Biotech Forum 2009.
-
Platform for high security virus purification
Millipore Corporation has introduced the Viresolve Pro Solution system, a new system for purification of viruses. The technology in the new platform includes a ...
-
Nya chefer på A1M
Rolf Gunnarsson och Eddie Thordarson ska driva på bolagets utveckling.
-
Oslo Cancer Cluster
Cancer is, of course, the focus for this Oslo-based cluster, which is solely dedicated to cancer treatment and diagnostics. Oslo cancer cluster is also a part o...
-
Beactica startar CNS-projekt med Janssen
Samarbetet inom fragmentbaserad läkemedelsutveckling utökas.
-
Få överraskningar i rapporten
Pledpharmas kvartalsrapport bjöd inte på några stora nyheter men planerna på diskussioner med FDA och potentiella samarbetspartners ligger fast.
-
Respiratorius hunts millions
The biopharmaceutical company Respiratorius has got a new CEO, who starts a public new share issue to catch almost SEK ten million.
-
New firm based on SLU research
Four researchers at the Swedish University of Agricultural Sciences, SLU, has recently founded a new nanotech company.
BREAKING